DataMEDS AI, Inc. MEDS
0.97 USD +0.07 (+8.10%)
Nov 11, 2026, 2:40 PM EST
0.8945 Day range 0.9899
0.823 52-week range 35.50
- YTD
- -95.16%
- 1 year
- -96.72%
News
benzinga.com FDA Flags Potential Vision Loss Risk With GLP-1 Drugs, Requiring Weight-Loss Medicines Like Wegovy and Zepbound to Carry New Warning FDA requires new NAION eye warning on all GLP-1 drugs, citing potential increased risk.
benzinga.com DataMeds AI's Corexa Pharmacy Unit Completes First Commercial Sale Of One Of Six FDA-Recommended Peptides Corexa Pharmacy subsidiary has completed its first commercial sale of one of the six peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax, together the "Six Peptides") recommended by the U.S.…
benzinga.com Datavault AI Fires CEO Nathaniel Bradley Datavault AI ousts CEO Nathaniel Bradley amid scrutiny over a $150M Bitcoin deal restatement and going-concern risks. Get the latest.
benzinga.com DataMeds AI Signs MoU With Florida HMO To Deploy The Health Lives Here Mobile App For GLP-1 Management DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
benzinga.com DataMeds AI Terminates Second Amended LOI With Datavault AI And Partners Due To Market Conditions; No Shares To Be Issued Under LOI, Existing REBOOT And Datavault Agreements Remain In Effect; Co Does Not Owe Any Fees Or Obligation As A Result Of The Termination DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
benzinga.com DataMEDS AI Moves Into Growing Peptide Market DataMEDS AI (MEDS) unit Corexa Health secures API supply for six peptides to begin dispensing in November 2026.
benzinga.com DataMeds AI's Pharmacy Unit Corexa Health Enters Agreement For Commercial Supply Of Six Peptides Recommended By The FDA Pharmacy Compounding Advisory Committee; Intends To Start Distributing Prescriptions In November 2026 DataMEDS intends to leverage the Health Lives Here mobile application to help collect and report safety data, in accordance with U.S. Health and Human Services' (HHS) Enforcement Discretion Policy…
benzinga.com DataMEDS AI Launches 'Health Lives Here' Community Respiratory Program To Be Marketed To 6,500+ Independent Pharmacies In Its Corexa Health Pharmacy Network Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026Program will aim to bring best…
benzinga.com DataMeds AI Signs LoI To Acquire Portion Of Quality Of Life Peace Of Mind IP Portfolio For Proprietary Position Until At Least 2042 DataMEDS AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
benzinga.com DataMeds AI Regains Compliance With Nasdaq Equity Rule DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-market session. The company's market cap stands at $2.1 billion. DataMEDS AI (NASDAQ:MEDS) shares moved…- benzinga.com DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Component On October 13, 2026 (the "Effective Date"), DataMeds AI, Inc. ("DataMeds" or the "Company") entered into an Intellectual Property License and Product and Services Agreement (the "IP License
- benzinga.com DataMeds AI To Collaborate With REBOOT Health AI To Integrate Its GLP Management Platform Into Its Health Lives Here Mobile App Under License Agreement DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its
benzinga.com DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test Humana includes DataMeds AI's Helomics ChemoFx assay in its Medicaid policy for gynecologic cancers, expanding payer reimbursement.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Mobile-health Network (NASDAQ:MNDR) shares increased by 141.2% to $2.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.0 million. DataMEDS AI…
benzinga.com Datameds AI Subsidiary Helomics Receives Medicaid Coverage Determination In Gynecologic Cancers For The ChemoFx Assay In Gynecologic Cancers DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company vertically integrating its Health IT and physical infrastructure- benzinga.com DataMeds AI Files DBAs For 'DataMeds SI' And 'Corexa Health SI' The Company also reminded shareholders of record as of the close of business on August 7, 2026 (the "Record Date") that the previously announced distribution (the "Distribution") of Dream Bowl Meme…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Nexalin Technology (NASDAQ:NXL) shares increased by 77.8% to $7.61 during Thursday's regular session. The company's market cap stands at $3.5 million. Stablecoin Development (AMEX:SDEV) stock…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-market session. The company's market cap stands at $10.1 million. Stablecoin Development (AMEX:SDEV)…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Kodiak Sciences (NASDAQ:KOD) shares moved upwards by 172.3% to $88.08 during Monday's regular session. The market value of their outstanding shares is at $2.0 billion. Accuray (NASDAQ:ARAY)…
benzinga.com Reported Earlier: DataMeds AI, Tollo Health Roll Out Health Lives Here Mobile Application DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence
benzinga.com DataMeds AI Stock Surges on Mobile App Launch DataMeds AI shares are surging Monday after launching a “Health Lives Here” mobile app with Tollo Health and the NFL Alumni Association.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Kodiak Sciences (NASDAQ:KOD) shares increased by 57.4% to $50.93 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Accuray (NASDAQ:ARAY)…
benzinga.com 'We Don't Know What the Risks Are': GLP-1 Pill Boom Fuels Hundreds of Apps, but Research Is Lagging Oral GLP-1 weight-loss pills are driving a health-tech boom, but research on their safe use is struggling to keep pace.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million. Cue Biopharma (NASDAQ:CUE) stock…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. Geovax Labs (NASDAQ:GOVX)…
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers IM Cannabis (NASDAQ:IMCC) stock increased by 246.0% to $6.02 during Friday's regular session. The market value of their outstanding shares is at $1.0 million. SkyAI (NASDAQ:SKYA) stock rose…
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. Alaunos Therapeutics (NASDAQ:TCRT)…
- benzinga.com Market-Moving News for September 18th TCRT: 69% | Alaunos Therapeutics On Thursday Filed Patent Application "Identification Of Neoantigen-Reactive T Cell Receptors" MEDS: 24% | DataMeds AI Settles Litigation Related To Outstanding Debt…
- benzinga.com DataMeds AI Settles Litigation Related To Outstanding Debt And Receivables Related To The 2023 Wellgistics Agreement; Company Retired ~364,099 MEDS Shares And Paid $450K In Cash Litigation related to outstanding debt and receivables related to the May 11, 2023 Wellgistics, LLC Membership Purchase Interest Agreement (the "Settlement Agreement") that were previously carried on…
benzinga.com DataMEDS AI Enters Settlement Agreement On Sept 11, 2026; Expects To Extinguish $19M In Liability From Agreement On September 11, 2026, DataMEDS AI, Inc. (the "Company") entered into a settlement agreement and release (the "Agreement") with Brian Norton, individually and as Seller Representative ("Norton"),- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular session. The market value of their outstanding shares is at $1.0 million. bioAffinity Technologies…
benzinga.com Dow Tumbles Over 600 Points as Fed Raises Rates: Investor Sentiment Weakens, Greed Index Remains in ‘Fear’ Zone Market fear deepened as CNN’s index fell to 26; stocks mostly declined after the Fed’s rate hike, with the Dow dropping 631 points.
benzinga.com Nebius Group, DataMEDS AI, Boeing, Generac Holdings and Delixy Holdings: Why These 5 Stocks Are on Investors' Radars Today Major U.S. indices ended Wednesday in the red as the Federal Reserve raised interest rates by 0.25%, marking the first increase since 2023. The Dow Jones Industrial Average fell 1.2% to 51,461.90,…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 354.9% to $7.37 during Wednesday's regular session. The company's market cap stands at $4.9 million. Q/C Technologies (NASDAQ:QCLS) shares…
benzinga.com Crude Oil Down Over 3%; US Business Inventories Surge In July U.S. stocks mixed: Dow slipped 0.1%, Nasdaq rose 0.7%, S&P 0.3%; tech led gains, energy fell, while oil dropped 3.2%.
benzinga.com DataMEDS AI Stock Surges Wednesday: What's Driving the Action? DataMEDS AI is surging Wednesday as investors digest the acquisition of an AI cancer diagnostics lab and contract research businesses.
benzinga.com Nasdaq Gains Over 100 Points; US Retail Sales Beat Estimates U.S. stocks edged higher as strong retail sales lifted sentiment; utilities gained, energy fell, oil dropped, while European and Asian markets advanced.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market session. The company's market cap stands at $4.9 million. Tempest Therapeutics (NASDAQ:TPST) stock moved…
- benzinga.com Market-Moving News for September 16th MEDS: 181% | DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute FTAI: 4% | FTAI Aviation shares are trading higher after the company…
benzinga.com Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks posted sharp premarket gains and losses.
benzinga.com DataMEDS AI Stock Soars 65% Pre-market: Here's What You Need to Know DataMEDS AI shares jumped 8.02% in overnight session Tuesday after the company completed its $1.5 million Helomics acquisition.
benzinga.com Veea Inc., DataMEDS AI, Trip.com, Datavault AI and Circle Internet Group: Why These 5 Stocks Are on Investors' Radars Today Major U.S. indices closed lower on Tuesday, with the Dow Jones Industrial Average falling 0.63% to 52,093.11.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular session. The market value of their outstanding shares is at $22.3 million. DataMEDS AI (NASDAQ:MEDS) shares…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market session. The company's market cap stands at $4.8 million. NewcelX (NASDAQ:NCEL) shares increased by…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2…
- benzinga.com DataMEDS AI Q2 EPS $(7.13) Down From $(5.40) YoY, Sales $1.780M Down From $7.791M YoY DataMEDS AI (NASDAQ:MEDS) reported quarterly losses of $(7.13) per share. This is a 32.04 percent decrease over losses of $(5.40) per share from the same period last year. The company reported $1.780…
- benzinga.com DataMeds AI Reports Pharmacy Unit Corexa Health July Sales Of $600K+ With Annual Run Rate $7M+; Corexa Completes Registration With TrumpRx To Offer Patients Access To Oral GLP-1 Agonist Drugs DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform
- benzinga.com DataMeds AI's Corexa Pharmacy Begins Direct-To-Consumer Distribution Of Tollovid And Galactovid Tollovid and Galactovid are marketed by Tollo Health, LLC ("Tollo Health"), a healthcare company focused on the commercialization of nutraceuticals that address specific mechanisms of action and…
- benzinga.com DataMeds AI, Datavault AI Amend Definitive Agreement To Expand PharmacyChain Blockchain-Related Technology Licensing Relationship Beyond Pharmaceutical Distribution DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide…